Can magnetic pulses to the brain boost speech in aphasia?
NCT ID NCT04188067
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether repeated sessions of transcranial magnetic stimulation (TMS) could improve language in people with primary progressive aphasia (PPA), a condition that slowly damages language areas of the brain. Ten participants received both real and sham (fake) TMS over ten days. Researchers measured changes in naming ability and brain connectivity to see if the stimulation helped.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- repetitive transcranial magnetic stimulation (rTMS)
- What this could lead to
- If it works, this could point toward a non-invasive treatment to temporarily improve language in people with primary progressive aphasia.
- What could go wrong
- This is a very small, early study with only 10 people. Benefits may be short-lived or not work for everyone. The condition is progressive, so any improvement may not last.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
10 people
The number who actually took part.
- Started
-
Mar 2022
- Finished
-
Aug 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 90 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Patients, age 18-90, who carry a diagnosis of either the logopenic (lvPPA), agrammatic non-fluent (nfvPPA) or semantic (svPPA) variants of Primary Progressive Aphasia (PPA). Patients must have been observed for at least one year by a specialized clinician. 2. Patients must have at least mild to moderate language impairment. 3. Patients must be native English speakers. 4. Patients must have a study partner (e.g. spouse, sibling or adult child) who can accompany them to every study visit. Exclusion Criteria: 1. Any history of seizures, unexplained loss of consciousness or a first-degree family member with epilepsy. 2. Any history of significant co-occurring neurological illness unrelated to neurodegeneration associated with PPA (e.g. multiple sclerosis), or significant medical problems (e.g. poorly controlled diabetes/hypertension or cancer within 5 years). 3. Active symptoms of major depressive disorder, bipolar disorder, schizophrenia, substance use disorder or significant premorbid intellectual disability according to Diagnostic Statistical Manual (DSM-5) criteria. 4. Magnetic Resonance Imaging (MRI) evidence of significant cerebrovascular disease, hydrocephalus or the presence of a space-occupying intra-cranial mass. Contraindications to MRI or repetitive transcranial magnetic stimulation (rTMS) including: cardiac pacemaker or pacemaker wires, neurostimulators, implanted pumps, metal in the body (rods, plates, screws, shrapnel, dentures, intrauterine device), surgical aneurysm clips in the head, previous neurosurgery or cochlear implants. 5. In line with published Massachusetts General Hospital (MGH) Institutional Review Board (IRB) guidelines for rTMS, pregnancy must be ruled out by urine ß-Human Chorionic Gonadotropin if answers to screening questions suggest that pregnancy is possible and if female participants are premenopausal and of child-bearing age. Subjects will not be able to enroll if they are breastfeeding.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Logopenic variant primary progressive aphasia are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02129, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- PET scans reveal how inflammation drives Alzheimer's variants
- Scientists map Brain's 'Roads' to predict dementia spread
- AI-powered brain zaps aim to slow language loss in dementia
- New study seeks to sharpen Alzheimer's diagnosis with simple tests
- Simple blood test could revolutionize Alzheimer's diagnosis
- Shock therapy at home? new trial tests brain zaps for speech loss